AI in Pharmacovigilance In-house Training

In this exciting new course, gain an introduction into the transformative impact of artificial intelligence on drug safety and monitoring.

★★★★★ "Very clear, focused in the important aspects of AI in PV and quite complete in content. I was expect... more"

Need help? Customise

Course overview

This course will provide a comprehensive introduction to the transformative impact of artificial intelligence on drug safety and monitoring. This course covers the fundamentals of AI technology, its applications in pharmacovigilance and practical insights into leveraging AI tools for efficient adverse event reporting, signal detection and risk management. Through a mix of theoretical knowledge and practical examples, participants will gain the understanding of available AI solutions in pharmacovigilance practices as well as current regulatory advances.

Browse our extensive selection of Life Sciences training courses for industry-leading insights into a range of topics. These include Medical Devices, IVDs, Biotech and Biopharma, Animal Health and Pharmaceutical training courses.

Benefits of attending

Learn how AI can streamline pharmacovigilance processes, reducing manual effort and increasing productivity
Discover AI's potential to improve the accuracy of adverse event detection and reporting
Understand application of AI in signal detection
Gain insights into how AI can help maintain and enhance compliance with regulatory requirements
Stay updated with the latest trends and advancements in AI applications within the pharmaceutical industry
Discover the ethical considerations and best practices for implementing AI in pharmacovigilance

Who should attend?

Pharmacovigilance specialists
Drug safety officers
Regulatory affairs professionals
Clinical research associates
Medical affairs personnel
Data scientists working in healthcare and pharmaceuticals

This course will cover:

Introduction to the basics of AI

Key AI technologies: machine learning, natural language processing and automation
Overview of AI and its relevance to pharmacovigilance

AI for adverse event detection and reporting

AI methods for identifying adverse events from diverse data sources
Case studies on successful AI implementations in adverse event reporting

AI in drug discovery and drug repurposing

Utilising AI for signal detection and analysis
Case studies on AI and automation in signal detection

Ethical considerations and Regulatory landscape

Understanding regulatory guidelines for AI in pharmacovigilance
Ensuring AI applications meet regulatory standards
Ethical considerations of AI use

Future trends and innovations

Emerging AI technologies and their potential impact on pharmacovigilance
Preparing for the future: adapting to AI advancements

Graeme Ladds
PharSafer Associates Ltd

Graeme Ladds, Director of PharSafer, has over 30 years’ experience in the pharmaceutical industry. He began his career in 1989 at Ashbourne Pharmaceuticals as Head of Drug Safety & Medical Information, before going on to become Head of Global Pharmacovigilance at Shire Pharmaceuticals.

He later founded his consultancy and specialist CRO, PharSafer Associates Ltd, where he has supported companies in establishing pharmacovigilance systems, conducting audits across Europe and the USA, developing SOPs, acting as a QP, and supporting regulatory inspections.

Since 1994, Graeme has also been involved in the monitoring of medical devices, including drug–device combinations, structural devices and electrical medical devices. His experience spans clinical trials and global device vigilance, alongside pharmacovigilance activities across both clinical development and post-marketing phases.

More details

Reviews of IPI's AI in Pharmacovigilance training course

Very clear, focused in the important aspects of AI in PV and quite complete in content. I was expecting some general information on AI and its applicability in PV and I think this was fully accomplished. Very good.

Nov 19 2025

Claudio Branderley France
Senior Project Physician, UCB Pharma SA/UBC Pharma France

Mar 12 2025

My key objective was to understand for which processes AI can be used in terms of PV. I'm totally satisfied. Speaker very friendly and clear. Thank you.

Inga Michalczyk Germany
Scientific Manager Pharmacovigilance, SCRATCH Pharmacovigilance GmbH & Co. KG

Nov 19 2025

Good!

Ragunath MP India
Compliance Manager, Thermo Fisher Scientific

Mar 12 2025

The webinar provides an overview of the history and future of AI, and how it is used in the domain of pharmacovigilance. It provides you with practical examples, the pros of AI but also the obstacles. The speaker was well prepared and addressed our individual questions we had sent in upfront. She made it an interactive session which I greatly appreciated. Thanks to this webinar I now have a better view of the possibilities on how AI can be/is used for Pharmacovigilance (or Regulatory Affairs) daily tasks.

Els Christiaens Belgium
Regulatory Affairs Associate, Zoetis